C. Ola Landgren, MD, PhD
Advertisement

C. Ola Landgren, MD, PhD, is a professor of medicine, chief of the Division of Myeloma, Department of Medicine at the University of Miami, Miller School of Medicine; director of the Sylvester Myeloma Institute; co-leader of the Translational and Clinical Oncology Program and Paul J. DiMare Endowed Chair in immunotherapy at the Sylvester Comprehensive Cancer Center
Articles by C. Ola Landgren, MD, PhD
Advertisement
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
4
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
5

